Financials

News Ideas Discussions Technicals Forecast Seasonals Options

MREO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Mereo BioPharma Group plc operating, investing, and financing activities

MREO free cash flow for Q4 24 is -9.33 M USD. For 2024, MREO free cash flow was -32.85 M USD and operating cash flow was -32.85 M USD.

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—